Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
PLoS One
2008 Jul 23;37:e2746. doi: 10.1371/journal.pone.0002746.
Show Gene links
Show Anatomy links
A cytoplasmic domain mutation in ClC-Kb affects long-distance communication across the membrane.
Martinez GQ
,
Maduke M
.
Abstract
BACKGROUND: ClC-Kb and ClC-Ka are homologous chloride channels that facilitate chloride homeostasis in the kidney and inner ear. Disruption of ClC-Kb leads to Bartter's Syndrome, a kidney disease. A point mutation in ClC-Kb, R538P, linked to Bartter's Syndrome and located in the C-terminal cytoplasmic domain was hypothesized to alter electrophysiological properties due to its proximity to an important membrane-embedded helix. METHODOLOGY/PRINCIPAL FINDINGS: Two-electrode voltage clamp experiments were used to examine the electrophysiological properties of the mutation R538P in both ClC-Kb and ClC-Ka. R538P selectively abolishes extracellular calcium activation of ClC-Kb but not ClC-Ka. In attempting to determine the reason for this specificity, we hypothesized that the ClC-Kb C-terminal domain had either a different oligomeric status or dimerization interface than that of ClC-Ka, for which a crystal structure has been published. We purified a recombinant protein corresponding to the ClC-Kb C-terminal domain and used multi-angle light scattering together with a cysteine-crosslinking approach to show that the dimerization interface is conserved between the ClC-Kb and ClC-Ka C-terminal domains, despite the fact that there are several differences in the amino acids that occur at this interface. CONCLUSIONS: The R538P mutation in ClC-Kb, which leads to Bartter's Syndrome, abolishes calcium activation of the channel. This suggests that a significant conformational change--ranging from the cytoplasmic side of the protein to the extracellular side of the protein--is involved in the Ca(2+)-activation process for ClC-Kb, and shows that the cytoplasmic domain is important for the channel's electrophysiological properties. In the highly similar ClC-Ka (90% identical), the R538P mutation does not affect activation by extracellular Ca(2+). This selective outcome indicates that ClC-Ka and ClC-Kb differ in how conformational changes are translated to the extracellular domain, despite the fact that the cytoplasmic domains share the same quaternary structure.
Figure 1. CLC domain architecture and the location of R538.(A) Homology model of ClC-Kb using ClC-ec1 (1OTS) as a template for the membrane domain and the ClC-Ka C-terminal domain structure (2PFI) as a template for the cytoplasmic domain. Subunit A (grey) has several amino acids removed to show the ion coordination of chloride by Y520 (in spacefill), located on helix-R. R538 is located in the cytoplasmic-domain loop (red) that connects helix-R to CBSD1. (B) Structure of the ClC-Ka C-terminal domain (2PFI) highlighting the different CBSDs. Subunit 1 has CBSD1 in blue and CBSD2 in cyan; subunit 2 has CBSD1 in red and CBSD2 in violet. (C) Structure of TM0935 (1OTS) with the color scheme as in B. All cartoons were generated in PyMol (http://www.pymol.org).
Figure 2. Gating and selectivity of ClC-Kb-R538P.Two-electrode voltage clamp recordings of (A) wild type and (B) R538P ClC-Kb channels. Currents are in response to a 200-ms prepulse to +60 mV followed by 500-ms test pulses ranging from +60 mV to −140 mV in −20 mV decrements. (C) Steady-state currents at the different voltages were normalized to the current value at +60 mV for wild type (filled squares) and R538P (open squares). Error bars are s.e.m. with n = 8 (WT) and n = 6 (R538P). Error bars smaller than the symbols are not shown. Representative steady state I–V curves for (D) wild type and (E) R538P channels in the presence of chloride (filled squares), bromide (open squares), or iodide (open diamonds). (F) Permeability ratios relative to chloride for wild type (filled bars) and R538P (open bars). The bromide/chloride permeability ratio of R538P is statistically different from that of wild type (p<0.0005, n = 5).
Figure 3. R538P abolishes calcium activation in hClC-Kb.Current recordings for (A) wild type and (B) R538P ClC-Kb channels at 0.1 mM calcium (left) and 10.0 mM calcium (right). (C) Calcium dependent activation of wild type (filled squares) and R538P (open squares) channels. Steady-state current levels at +60 mV plotted as a function of [Ca2+], normalized to the value at 0.1 mM calcium. Each data point is the average of several (n = 4–6) oocytes and error bars show the s.e.m. Only oocytes that showed reversibility were included in the analysis.
Figure 4. Expression of hClC-Ka-R538P.Two-electrode voltage clamp current recordings of wild type (A) and R538P (B) expressing channels. Currents are in response to a 100-ms prepulse to +60 mV follow by 500-ms test pulses ranging from +60 mV to −140 mV in −20 mV steps. (C) Relative permeability ratios for ClC-Ka wild type (filled bars) and R538P (open bars) channels. The iodide/chloride permeability ratio of R538P is statistically different from that of wild type (p<0.02, n = 3 (WT) and n = 5 (R538P)). (D) Calcium dependence at +60 mV of wild type (open squares) and R538P (open triangles) normalized to the current at +60 mV in the presence of 0.1 mM calcium, as in Figure 3. Error bars for WT (n = 4) and R538P (n = 3) are the s.e.m.
Figure 5. Dimerization of the ClC-Kb C-terminal domain.(A) Stereo view of the ClC-Ka cytoplasmic domain structure (2PFI) with amino acid differences between ClC-Ka and ClC-Kb shown in space fill. Amino acid F636 (shown in black) is on the dimer interface in ClC-Ka and when mutated to aspartic acid removes ClC-Ka dimerization. In ClC-Kb this residue is the non-polar residue serine. (B) Gel filtration combined with multi-angle light scattering shows that the C-terminal domain of ClC-Kb forms a dimer in solution. The solid line represents the absorbance at 280 nm as a function of elution volume. Filled circles represent the calculated mass at the different elution volumes. The molar mass was determined to be 37 kDa, consistent with dimerization.
Figure 6. Conserved dimerization interface in the ClC-Kb C-terminal domain.(A) Stereo view of TM0935 structure (1O50), a CBSD-containing protein that adopts an alternate dimer interface. Amino acids corresponding to residues that differ between ClC-Ka and ClC-Kb are shown in spacefill. The residue corresponding to 636 in ClC-Kb (see Figure 5A) is shown in black. (B) Residues chosen for cross-linking studies mapped onto the ClC-Ka C-terminal domain structure: L650 (black), 603 (cyan), 604 (green), 644 (olive), 645 (magenta). For this dimer interface, the L650C mutant is expected to form an intersubunit cross-link. (C) Residues chosen for cross-linking studies mapped onto the TM0935 structure; color scheme as in B. For this dimer interface, the 603–645 and the 604–644 cysteine double mutants are expected to form intersubunit cross-links. (D) SDS-PAGE of purified ClC-Kb C-terminal domains with different cysteine mutations in reducing (−) and oxidizing (+) conditions.
Bateman,
The structure of a domain common to archaebacteria and the homocystinuria disease protein.
1997, Pubmed
Bateman,
The structure of a domain common to archaebacteria and the homocystinuria disease protein.
1997,
Pubmed
Beck,
Molecular basis for decreased muscle chloride conductance in the myotonic goat.
1996,
Pubmed
,
Xenbase
Carr,
A role for CBS domain 2 in trafficking of chloride channel CLC-5.
2003,
Pubmed
Cleiren,
Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene.
2001,
Pubmed
Cox,
Renal chloride channel, CLCN5, mutations in Dent's disease.
1999,
Pubmed
Daniel,
Functional analysis of mutations in the gamma 2 subunit of AMP-activated protein kinase associated with cardiac hypertrophy and Wolff-Parkinson-White syndrome.
2002,
Pubmed
Day,
Structure of a CBS-domain pair from the regulatory gamma1 subunit of human AMPK in complex with AMP and ZMP.
2007,
Pubmed
Engh,
Cysteine accessibility in ClC-0 supports conservation of the ClC intracellular vestibule.
2005,
Pubmed
,
Xenbase
Estévez,
Barttin is a Cl- channel beta-subunit crucial for renal Cl- reabsorption and inner ear K+ secretion.
2001,
Pubmed
,
Xenbase
Estévez,
CLC chloride channels: correlating structure with function.
2002,
Pubmed
Estévez,
Functional and structural conservation of CBS domains from CLC chloride channels.
2004,
Pubmed
,
Xenbase
Fong,
Determinants of slow gating in ClC-0, the voltage-gated chloride channel of Torpedo marmorata.
1998,
Pubmed
,
Xenbase
Fukuyama,
Novel mutations of the chloride channel Kb gene in two Japanese patients clinically diagnosed as Bartter syndrome with hypocalciuria.
2004,
Pubmed
Günther,
The ClC-5 chloride channel knock-out mouse - an animal model for Dent's disease.
2003,
Pubmed
Haug,
Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies.
2003,
Pubmed
Hayama,
Molecular mechanisms of Bartter syndrome caused by mutations in the BSND gene.
2003,
Pubmed
Hebert,
Bartter syndrome.
2003,
Pubmed
Heils,
CLCN2 and idiopathic generalized epilepsy.
2005,
Pubmed
Ignoul,
CBS domains: structure, function, and pathology in human proteins.
2005,
Pubmed
Janosík,
Regulation of human cystathionine beta-synthase by S-adenosyl-L-methionine: evidence for two catalytically active conformations involving an autoinhibitory domain in the C-terminal region.
2001,
Pubmed
Jeck,
Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype.
2000,
Pubmed
Jentsch,
Physiological functions of CLC Cl- channels gleaned from human genetic disease and mouse models.
2005,
Pubmed
Jentsch,
CLC chloride channels and transporters: from genes to protein structure, pathology and physiology.
2008,
Pubmed
Jentsch,
Molecular structure and physiological function of chloride channels.
2002,
Pubmed
Jentsch,
Myotonias due to CLC-1 chloride channel mutations.
1995,
Pubmed
Koch,
The skeletal muscle chloride channel in dominant and recessive human myotonia.
1992,
Pubmed
Kondo,
Effect of Ca2+ on Cl- transport in thin ascending limb of Henle's loop.
1988,
Pubmed
Konrad,
Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome.
2000,
Pubmed
Kornak,
Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man.
2001,
Pubmed
Kubisch,
ClC-1 chloride channel mutations in myotonia congenita: variable penetrance of mutations shifting the voltage dependence.
1998,
Pubmed
,
Xenbase
Lin,
Probing the pore of ClC-0 by substituted cysteine accessibility method using methane thiosulfonate reagents.
2003,
Pubmed
Lloyd,
A common molecular basis for three inherited kidney stone diseases.
1996,
Pubmed
,
Xenbase
Maduke,
Formation of CLC-0 chloride channels from separated transmembrane and cytoplasmic domains.
1998,
Pubmed
,
Xenbase
Markovic,
The structure of the cytoplasmic domain of the chloride channel ClC-Ka reveals a conserved interaction interface.
2007,
Pubmed
Matulef,
The CLC 'chloride channel' family: revelations from prokaryotes.
2007,
Pubmed
Meyer,
Crystal structure of the cytoplasmic domain of the chloride channel ClC-0.
2006,
Pubmed
Meyer,
Nucleotide recognition by the cytoplasmic domain of the human chloride transporter ClC-5.
2007,
Pubmed
,
Xenbase
Miller,
Crystal structure of a tandem cystathionine-beta-synthase (CBS) domain protein (TM0935) from Thermotoga maritima at 1.87 A resolution.
2004,
Pubmed
Mo,
Coexpression of complementary fragments of ClC-5 and restoration of chloride channel function in a Dent's disease mutation.
2004,
Pubmed
,
Xenbase
Mupanomunda,
Renal interstitial Ca(2+).
2000,
Pubmed
Niemeyer,
Functional evaluation of human ClC-2 chloride channel mutations associated with idiopathic generalized epilepsies.
2004,
Pubmed
Nozu,
Molecular analysis of digenic inheritance in Bartter syndrome with sensorineural deafness.
2008,
Pubmed
Piwon,
ClC-5 Cl- -channel disruption impairs endocytosis in a mouse model for Dent's disease.
2000,
Pubmed
Poët,
Lysosomal storage disease upon disruption of the neuronal chloride transport protein ClC-6.
2006,
Pubmed
Proudfoot,
Biochemical and structural characterization of a novel family of cystathionine beta-synthase domain proteins fused to a Zn ribbon-like domain.
2008,
Pubmed
Pusch,
Myotonia caused by mutations in the muscle chloride channel gene CLCN1.
2002,
Pubmed
Rodríguez-Soriano,
A founder mutation in the CLCNKB gene causes Bartter syndrome type III in Spain.
2005,
Pubmed
Schmidt-Rose,
Reconstitution of functional voltage-gated chloride channels from complementary fragments of CLC-1.
1997,
Pubmed
,
Xenbase
Schwappach,
Golgi localization and functionally important domains in the NH2 and COOH terminus of the yeast CLC putative chloride channel Gef1p.
1998,
Pubmed
Stogmann,
Mutations in the CLCN2 gene are a rare cause of idiopathic generalized epilepsy syndromes.
2006,
Pubmed
Uchida,
Localization and functional characterization of rat kidney-specific chloride channel, ClC-K1.
1995,
Pubmed
,
Xenbase
Uchida,
Function of chloride channels in the kidney.
2005,
Pubmed
Vargas-Poussou,
Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome.
2002,
Pubmed
Waldegger,
Functional and structural analysis of ClC-K chloride channels involved in renal disease.
2000,
Pubmed
,
Xenbase
Wang,
Mice lacking renal chloride channel, CLC-5, are a model for Dent's disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis.
2000,
Pubmed
Watanabe,
Association between activating mutations of calcium-sensing receptor and Bartter's syndrome.
2002,
Pubmed
Zelikovic,
A novel mutation in the chloride channel gene, CLCNKB, as a cause of Gitelman and Bartter syndromes.
2003,
Pubmed
Zhang,
Characteristics and crystal structure of bacterial inosine-5'-monophosphate dehydrogenase.
1999,
Pubmed
Zifarelli,
CLC chloride channels and transporters: a biophysical and physiological perspective.
2007,
Pubmed